Zhang S-J, Ma J, Wu J-C, Hao Z-Z, Zhang Y-N, Zhang Y-J
Department of Respiratory Medicine, Huaihe Hospital of Henan University, Kaifeng, China.
Eur Rev Med Pharmacol Sci. 2021 Apr;25(8):3150. doi: 10.26355/eurrev_202104_25716.
The article "CircRNA EPB41L2 inhibits tumorigenicity of lung adenocarcinoma through regulating CDH4 by miR-211-5p, by S.-J. Zhang, J. Ma, J.-C. Wu, Z.-Z. Hao, Y.-N. Zhang, Y.-J. Zhang, published in Eur Rev Med Pharmacol Sci 2020; 24 (7): 3749-3760-DOI: 10.26355/eurrev_202004_20839-PMID: 32329852" has been withdrawn from the authors due to inaccuracies and mistakes. The Publisher apologizes for any inconvenience this may cause. https://www.europeanreview.org/article/20839.
文章《环状RNA EPB41L2通过miR - 211 - 5p调控CDH4抑制肺腺癌的致瘤性》,作者为张思佳、马杰、吴建超、郝志忠、张亚宁、张亚军,发表于《欧洲医学与药理学评论》2020年;24(7):3749 - 3760 - DOI: 10.26355/eurrev_202004_20839 - PMID: 32329852,因存在不准确和错误已被作者撤回。出版商对由此可能造成的任何不便表示歉意。https://www.europeanreview.org/article/20839